| 5FD2: B-Raf Wild-Type Kinase Domain In Complex With A Purinylpyrid Based Inhibitor reference: Purinylpyridinylamino-based DFG-in/alphaC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling., Liu L, Lee MR, Kim JL, Whittington DA, Bregman H, Hua Z, Lewis RT, Martin MW, Nishimura N, Potashman M, Yang K, Yi S, Vaida KR, Epstein LF, Babij C, Fernando M, Carnahan J, Norman MH, Bioorg Med Chem. 2016 May 15;24(10):2215-34. doi: 10.1016/j.bmc.2016.03.055. Epub, 2016 Apr 13. PMID: 27085672 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).